Predictors of overall survival in metastatic castration-resistant prostate cancer patients receiving [177Lu]Lu-PSMA-617 radioligand therapy
2015 ◽
Vol 21
(14)
◽
pp. 3170-3177
◽
2019 ◽
Vol 60
(11)
◽
pp. 1579-1586
◽
2018 ◽
Vol 17
(2)
◽
pp. e875-e876
◽
2019 ◽
Vol 61
(1)
◽
pp. 62-69
◽
2018 ◽
Vol 16
(3)
◽
pp. 184-190.e2
◽
2021 ◽